Cite
HARVARD Citation
Seet, A. et al. (n.d.). 430PPhase I study: Safety and tolerability of varlitinib (VAR) in combination with oxaliplatin and capecitabine (COX) or oxaliplatin and 5-FU (FOL) in advanced solid tumours. Annals of oncology. p. . [Online].